🚀 VC round data is live in beta, check it out!
Ingevity Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ingevity and similar public comparables like Quaker Houghton, Chemours, Saudi Industrial Investment Group, Hexpol and more.
Ingevity Overview
About Ingevity
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.
Founded
2015
HQ
Employees
1.7K
Website
Sectors
Financials (LTM)
EV
$4B
Ingevity Financials
Ingevity reported last 12-month revenue of $1B and EBITDA of $396M.
In the same LTM period, Ingevity generated $435M in gross profit, $396M in EBITDA, and had net loss of ($97M).
Revenue (LTM)
Ingevity P&L
In the most recent fiscal year, Ingevity reported revenue of $1B and EBITDA of $398M.
Ingevity expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $435M | XXX | $462M | XXX | XXX | XXX |
| Gross Margin | 37% | XXX | 40% | XXX | XXX | XXX |
| EBITDA | $396M | XXX | $398M | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | 34% | XXX | XXX | XXX |
| EBIT Margin | 25% | XXX | 25% | XXX | XXX | XXX |
| Net Profit | ($97M) | XXX | ($167M) | XXX | XXX | XXX |
| Net Margin | (8%) | XXX | (14%) | XXX | XXX | XXX |
| Net Debt | — | — | $1B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Ingevity Stock Performance
Ingevity has current market cap of $3B, and enterprise value of $4B.
Market Cap Evolution
Ingevity's stock price is $71.64.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $3B | 0.0% | XXX | XXX | XXX | $-4.65 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIngevity Valuation Multiples
Ingevity trades at 3.2x EV/Revenue multiple, and 9.6x EV/EBITDA.
EV / Revenue (LTM)
Ingevity Financial Valuation Multiples
As of March 17, 2026, Ingevity has market cap of $3B and EV of $4B.
Equity research analysts estimate Ingevity's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ingevity has a P/E ratio of (26.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 3.2x | XXX | 3.2x | XXX | XXX | XXX |
| EV/EBITDA | 9.6x | XXX | 9.5x | XXX | XXX | XXX |
| EV/EBIT | 13.1x | XXX | 13.1x | XXX | XXX | XXX |
| EV/Gross Profit | 8.7x | XXX | 8.2x | XXX | XXX | XXX |
| P/E | (26.5x) | XXX | (15.4x) | XXX | XXX | XXX |
| EV/FCF | 14.2x | XXX | 13.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ingevity Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Ingevity Margins & Growth Rates
Ingevity's revenue in the last 12 month grew by 1%.
Ingevity's revenue per employee in the last FY averaged $0.7M.
Ingevity's rule of 40 is 35% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ingevity's rule of X is 37% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Ingevity Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | 34% | XXX | XXX | XXX |
| EBITDA Growth | (1%) | XXX | (2%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 35% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 37% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.7M | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 17% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Ingevity Public Comps
See public comps and valuation multiples for other Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Quaker Houghton | XXX | XXX | XXX | XXX | XXX | XXX |
| Chemours | XXX | XXX | XXX | XXX | XXX | XXX |
| Saudi Industrial Investment Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Hexpol | XXX | XXX | XXX | XXX | XXX | XXX |
| Zeon | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ingevity M&A Activity
Ingevity acquired XXX companies to date.
Last acquisition by Ingevity was on XXXXXXXX, XXXXX. Ingevity acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Ingevity
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialIngevity Investment Activity
Ingevity invested in XXX companies to date.
Ingevity made its latest investment on XXXXXXXX, XXXXX. Ingevity invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Ingevity
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ingevity
| When was Ingevity founded? | Ingevity was founded in 2015. |
| Where is Ingevity headquartered? | Ingevity is headquartered in United States. |
| How many employees does Ingevity have? | As of today, Ingevity has over 1K employees. |
| Who is the CEO of Ingevity? | Ingevity's CEO is David H. Li. |
| Is Ingevity publicly listed? | Yes, Ingevity is a public company listed on NYSE. |
| What is the stock symbol of Ingevity? | Ingevity trades under NGVT ticker. |
| When did Ingevity go public? | Ingevity went public in 2016. |
| Who are competitors of Ingevity? | Ingevity main competitors are Quaker Houghton, Chemours, Saudi Industrial Investment Group, Hexpol. |
| What is the current market cap of Ingevity? | Ingevity's current market cap is $3B. |
| What is the current revenue of Ingevity? | Ingevity's last 12 months revenue is $1B. |
| What is the current revenue growth of Ingevity? | Ingevity revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Ingevity? | Current revenue multiple of Ingevity is 3.2x. |
| Is Ingevity profitable? | Yes, Ingevity is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ingevity? | Ingevity's last 12 months EBITDA is $396M. |
| What is Ingevity's EBITDA margin? | Ingevity's last 12 months EBITDA margin is 34%. |
| What is the current EV/EBITDA multiple of Ingevity? | Current EBITDA multiple of Ingevity is 9.6x. |
| What is the current FCF of Ingevity? | Ingevity's last 12 months FCF is $267M. |
| What is Ingevity's FCF margin? | Ingevity's last 12 months FCF margin is 23%. |
| What is the current EV/FCF multiple of Ingevity? | Current FCF multiple of Ingevity is 14.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.